Calais Philippe has filed 3 insider transactions across 1 company since May 2023.
Most recent transaction: a grant/award of 70000 shares of Transcode Therapeutics, Inc. ($RNAZ) on June 14, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 14, 2024 | Transcode Therapeutics, Inc. | $RNAZ | Calais Philippe | Director | A | Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 155,831 | 9999.99% | 44.92% |
| May 19, 2023 | Transcode Therapeutics, Inc. | $RNAZ | Calais Philippe | Director | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 18,593 | 9999.99% | 100.00% |
| May 10, 2023 | Transcode Therapeutics, Inc. | $RNAZ | Calais Philippe | Director | A | Stock Option (Right to Buy) | 9500 | $0.00 | 9,500.0000 | 18,593 | 9999.99% | 51.09% |